Literature DB >> 23835744

Temperature-sensitive mutants ofStaphylococcus aureus: Isolation and preliminary characterization.

D O Sordelli1, M F Iglesias, M C Cerquetti, M Catalano, A M Hooke.   

Abstract

Temperature-sensitive (ts) mutants ofStaphylococcus aureus were isolated after mutagenesis with nitrosoguanidine and two cycles of enrichment with Penicillin G and D-Cycloserine. The mutants expressed tight, coasting, and leaky phenotypes on solid media. In broth, however, most exhibited coasting for a limited number of generations. The reversion frequency of selected ts mutants was less than 10(-6). Intraperitoneal (i.p.) immunization with ts mutant G/1/2 conferred significant protection (0 dead/6 total vs. 7/7, immunized vs. control; p=0.0006) from lethal i.p. challenge with the parental wild-type (wt)S. aureus suspended in 5% porcine mucin, performed 28 days after i.p. administration of 10(8) colony-forming units. Protection induced by mutants of coasting phenotype was higher and lasted longer than that induced by mutants of the tight phenotype. The results of this study demonstrate that ts mutants ofS. aureus can be obtained and that ts mutants are able to induce protective immunity from subsequent challenge with the parental wt strain.

Entities:  

Year:  1993        PMID: 23835744     DOI: 10.1007/BF01576008

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  15 in total

1.  Staphylococcal mastitis vaccine.

Authors:  D L Watson
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies.

Authors:  A Kärnell; B A Stocker; S Katakura; F P Reinholt; A A Lindberg
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

Review 3.  Polysaccharide-protein conjugates: a new generation of vaccines.

Authors:  J B Robbins; R Schneerson
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

Review 4.  Potential for vaccination against infections caused by Staphylococcus aureus.

Authors:  T J Foster
Journal:  Vaccine       Date:  1991-04       Impact factor: 3.641

Review 5.  Vaccination against mastitis.

Authors:  R W Mellenberger
Journal:  J Dairy Sci       Date:  1977-06       Impact factor: 4.034

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Live attenuated bacterial vaccines: new approaches for safety and efficacy.

Authors:  A M Hooke; J A Bellanti; M P Oeschger
Journal:  Lancet       Date:  1985-06-29       Impact factor: 79.321

8.  Application of small fragment restriction endonuclease analysis (SF-REA) to the epidemiological fingerprinting of Staphylococcus aureus.

Authors:  R Haertl; G Bandlow
Journal:  J Med Microbiol       Date:  1990-10       Impact factor: 2.472

9.  Slime production by bovine milk Staphylococcus aureus and identification of coagulase-negative staphylococcal isolates.

Authors:  P N Rather; A P Davis; B J Wilkinson
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

10.  Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.

Authors:  A Fattom; R Schneerson; S C Szu; W F Vann; J Shiloach; W W Karakawa; J B Robbins
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.609

View more
  2 in total

1.  Bovine and rabbit models for the study of a Staphylococcus aureus avirulent mutant strain, RC122.

Authors:  Elina Reinoso; Gabriel Magnano; Jose Giraudo; Aldo Calzolari; Cristina Bogni
Journal:  Can J Vet Res       Date:  2002-10       Impact factor: 1.310

2.  Induction of cell-mediated immunity to Staphylococcus aureus in the mouse mammary gland by local immunization with a live attenuated mutant.

Authors:  Marisa I Gómez; Daniel O Sordelli; Fernanda R Buzzola; Verónica E García
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.